Atea Pharmaceuticals Inc (AVIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 30,713 | -10,947 | -31,603 | -13,981 | -3,988 |
| Depreciation Amortization | 7 | 19 | 13 | 8 | 4 |
| Accounts receivable | N/A | -5,815 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 3,732 | -488 | 3,689 | 2,643 | -150 |
| Other Working Capital | -54,830 | 300,205 | 5,167 | 1,269 | -713 |
| Other Operating Activity | 3,541 | 13,760 | 947 | -2,245 | 339 |
| Operating Cash Flow | $-16,837 | $296,734 | $-21,787 | $-12,306 | $-4,508 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -26 | -21 | -6 | N/A |
| Investing Cash Flow | $N/A | $-26 | $-21 | $-6 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 471 | 317,632 | 27 | 27 | -6 |
| Other Financing Activity | 0 | 214,116 | 105,503 | 106,416 | 0 |
| Financing Cash Flow | $471 | $531,748 | $105,530 | $106,443 | $-6 |
| Beginning Cash Position | 850,224 | 21,768 | 21,768 | 21,768 | 21,768 |
| End Cash Position | 833,858 | 850,224 | 105,490 | 115,899 | 17,254 |
| Net Cash Flow | $-16,366 | $828,456 | $83,722 | $94,131 | $-4,514 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,837 | 296,734 | -21,787 | -12,306 | -4,508 |
| Capital Expenditure | N/A | -26 | -21 | -6 | N/A |
| Free Cash Flow | -16,837 | 296,708 | -21,808 | -12,312 | -4,508 |